Medizin und Ökonomie - Freunde oder Feinde?

Brügger, Urs

doi:10.1024/0040-5930/a000864

Full metadata record

DC Field	Value	Language
dc.contributor.author	Brügger, Urs	-
dc.date.accessioned	2019-03-08T07:25:24Z	-
dc.date.available	2019-03-08T07:25:24Z	-
dc.date.issued	2017	-
dc.identifier.issn	0040-5930	de_CH
dc.identifier.issn	1664-2864	de_CH
dc.identifier.uri	https://digitalcollection.zhaw.ch/handle/11475/15914	-
dc.description.abstract	The healthcare sector is booming. In many areas the Swiss health system tends to provide excessive medical care and, thus, generates overuse and waste. In others however, medical care is insufficient. “Economisation” is often blamed for both misdevelopments. People talk about false incentives and commodification, but they also talk about excessive savings and rationing. Health is not a commodity like any other. It is, beyond any doubt, one of the most important goods. There are good economic reasons why health care is not left to the free market. In order for the system to work without a market mechanism, economic tools, such as health-economic evaluations and tariffs are needed. It is of great importance which medical services are reimbursed and how high the reimbursement is. Unfortunately, these tools have also undesirable side effects. Medical services should primarily focus on the medical necessity, not on economic interests. “Indication quality” is an essential condition to avoid excessive, insufficient or inappropriate medical care. Secondly, the care providers must offer efficient services. This is why approaches such as “lean management”, which have long been used in other industries, have found their way into the healthcare sector. “Value” is only created in the healthcare sector if patients receive the appropriate medical care, and if the medical care, and if those services are provided in an efficient way. Only then the criteria of “effectiveness, appropriateness and cost-effectiveness”, stipulated by the Health Insurance law for the reimbursement of services are fulfilled. This is in the interest of both patients and society as well well as in the spirit of medicine and economics.	de_CH
dc.language.iso	de	de_CH
dc.publisher	Hogrefe	de_CH
dc.relation.ispartof	Therapeutische Umschau	de_CH
dc.rights	Licence according to publishing contract	de_CH
dc.subject.ddc	362.1041: Gesundheitsökonomie	de_CH
dc.title	Medizin und Ökonomie - Freunde oder Feinde?	de_CH
dc.type	Beitrag in wissenschaftlicher Zeitschrift	de_CH
dcterms.type	Text	de_CH
zhaw.departement	School of Management and Law	de_CH
dc.identifier.doi	10.1024/0040-5930/a000864	de_CH
zhaw.funding.eu	No	de_CH
zhaw.issue	1	de_CH
zhaw.originated.zhaw	Yes	de_CH
zhaw.pages.end	785	de_CH
zhaw.pages.start	777	de_CH
zhaw.publication.status	publishedVersion	de_CH
zhaw.volume	74	de_CH
zhaw.publication.review	Peer review (Publikation)	de_CH
Appears in collections:	Publikationen School of Management and Law

Files in This Item:

There are no files associated with this item.

Show simple item record

Brügger, U. (2017). Medizin und Ökonomie - Freunde oder Feinde? Therapeutische Umschau, 74(1), 777–785. https://doi.org/10.1024/0040-5930/a000864

Brügger, U. (2017) ‘Medizin und Ökonomie - Freunde oder Feinde?’, Therapeutische Umschau, 74(1), pp. 777–785. Available at: https://doi.org/10.1024/0040-5930/a000864.

U. Brügger, “Medizin und Ökonomie - Freunde oder Feinde?,” Therapeutische Umschau, vol. 74, no. 1, pp. 777–785, 2017, doi: 10.1024/0040-5930/a000864.

BRÜGGER, Urs, 2017. Medizin und Ökonomie - Freunde oder Feinde? Therapeutische Umschau. 2017. Bd. 74, Nr. 1, S. 777–785. DOI 10.1024/0040-5930/a000864

Brügger, Urs. 2017. “Medizin und Ökonomie - Freunde oder Feinde?” Therapeutische Umschau 74 (1): 777–85. https://doi.org/10.1024/0040-5930/a000864.

Brügger, Urs. “Medizin und Ökonomie - Freunde oder Feinde?” Therapeutische Umschau, vol. 74, no. 1, 2017, pp. 777–85, https://doi.org/10.1024/0040-5930/a000864.